Phase I to II study of pleurectomy/decortication and intraoperative intracavitary hyperthermic cisplatin lavage for mesothelioma.
about
Clinical outcomes of cytoreductive surgery combined with intrapleural perfusion of hyperthermic chemotherapy in advanced lung adenocarcinoma with pleural disseminationIncreased efficacy of doxorubicin delivered in multifunctional microparticles for mesothelioma therapyA multifunctional mesothelin antibody-tagged microparticle targets human mesotheliomasReactive oxygen species a double-edged sword for mesotheliomaGuidelines for the diagnosis and treatment of malignant pleural mesotheliomaSurgical treatment of malignant pleural mesothelioma.Extrapleural pneumonectomy (EPP) vs. pleurectomy decortication (P/D).Intraoperative intracavitary hyperthermic chemotherapy for malignant pleural mesothelioma.Genes associated with prognosis after surgery for malignant pleural mesothelioma promote tumor cell survival in vitro.Anaesthetic management of cytoreductive surgery followed by hyperthermic intrathoracic chemotherapy perfusionExtrapleural pneumonectomy or pleurectomy/decortication for malignant pleural mesothelioma.New and emerging therapeutic options for malignant pleural mesothelioma: review of early clinical trials.Simple intrapleural hyperthermia at thoracoscopic exploration to treat malignant pleural effusionDocetaxel in the treatment of gastric cancer.Hyperthermia, cisplatin and radiation trimodality treatment: a promising cancer treatment? A review from preclinical studies to clinical application.Laboratory and clinical basis for hyperthermia as a component of intracavitary chemotherapy.Trimodality strategy for treating malignant pleural mesothelioma: results of a feasibility study of induction pemetrexed plus cisplatin followed by extrapleural pneumonectomy and postoperative hemithoracic radiation (Japan Mesothelioma Interest GrouFour-gene expression ratio test for survival in patients undergoing surgery for mesothelioma.Management of malignant pleural mesothelioma-part 2: therapeutic approaches : Consensus of the Austrian Mesothelioma Interest Group (AMIG).Randomized clinical studies of anti-tumor vaccination: state of the art in 2008.Comprehensive management of peritoneal surface malignancy using cytoreductive surgery and perioperative intraperitoneal chemotherapy: the Washington Cancer Institute approach.Introducing a new entity: chemotherapy-induced arrhythmia.Making the case for molecular staging of malignant pleural mesothelioma.Surgery for malignant pleural mesothelioma.Changes in lung function after surgery for mesothelioma.Management of malignant pleural mesothelioma-The European experience.Local and systemic therapies for malignant pleural mesothelioma.Cancer chemotherapy and cardiac arrhythmias: a review.Current surgical strategies for malignant pleural mesothelioma.Arrhythmias and Other Electrophysiology Issues in Cancer Patients Receiving Chemotherapy or Radiation.Cytoreductive surgery and hyperthermic intrapleural chemotherapy for malignant pleural diseases: preliminary experience.Intraoperative adjuncts for malignant pleural mesothelioma.Mesothelioma cells escape heat stress by upregulating Hsp40/Hsp70 expression via mitogen-activated protein kinases.Pleurectomy and decortication.Updated patterns of failure after multimodality therapy for malignant pleural mesothelioma.The evolution of multimodality therapy for malignant pleural mesotheliomaStandardizing surgical treatment in malignant pleural mesothelioma.Multimodality therapy for malignant pleural mesothelioma.Effect of hyperthermic intrathoracic chemotherapy on the malignant pleural mesothelioma: a systematic review and meta-analysis.Malignant mesothelioma as a difficult interdisciplinary problem.
P2860
Q26779613-7000F84F-E7AF-4C23-A696-CA862C058C06Q28385656-4F7490AA-C049-4FF0-86A8-7988A13AF87AQ28392105-9F417B92-5549-4EFD-9615-6143C5B63CC5Q28392665-BEB6B2D9-1777-47D7-AF56-9206F42FCA9DQ28394028-516BB67C-50DB-4F92-AC91-E7EC3A607B8CQ30401535-07B0A9A4-47DA-4CF1-A765-BF6B6FBEC4A2Q33871592-ACE989D2-8DE2-4E2E-992F-611E7EB2B80BQ33871630-D0335CF0-3838-4880-BBFB-248097E78317Q33899105-E71CF4E9-11CC-46EC-803B-16F95214C58CQ34009355-A81236FE-9787-418E-B939-EA34B68A8480Q34130373-AA9AFAA5-2704-49CF-B1C3-A112143E6149Q35042668-92E3C937-42AF-4B99-8DAA-F2C2B46164A8Q36224299-94C5669E-3E09-4958-BD94-45F4CEDE481EQ36616503-C8A2821C-937A-405E-8C87-506F2125242CQ36844934-4AA45851-F63F-47CD-9FE1-DC60782BE2C2Q36911440-6CEB23C9-BC26-434F-A374-FBF72715F46BQ36990070-47C9A122-2360-4F56-BD65-28DE5E146202Q37180702-234A94C9-A278-4FAB-BD9B-53C11076ABA4Q37277434-796EAEBA-989E-465D-AC81-C7B2D1C95426Q37354177-DD6B8215-26EE-47C1-BDB2-211EF180CAD1Q37534736-9E450B6E-A2AA-4CDE-B5A1-C33600D91556Q37607920-DB2D8615-D2BD-463B-8396-AB9E963C556BQ37613240-7C34D971-FBD0-4094-99EB-794312BADD72Q37762833-CF118B2F-839A-4F2E-ACD6-68F230238E30Q38083599-CC31B03D-DC1B-4547-AAB6-D769B532CC1EQ38215513-4DE2C852-3119-485B-BAD1-31CB643A1067Q38255347-F22C312D-A7C7-4181-84D9-FCA56A22E14BQ38313870-5AB4610B-1474-498D-9707-BF8981615761Q38641574-ECBE2DD0-4892-46F0-AABE-8A5399700B72Q38815946-0FE538E6-68DB-40AA-ADF9-F0B5A977C356Q39041991-C876D547-0A54-45C6-B6EF-9D46639DAF26Q39438165-ED9C3AFF-C32B-4FBB-9194-4D88816DD787Q39834009-B1744A46-1C31-4879-9382-28599937B08BQ40964739-F835AB4A-EFB8-4272-BFA8-97BAAB722ECDQ41220761-669B342F-C8F2-43CD-96EA-F8FA5E414F11Q42019544-CD36922E-A933-4303-883B-6C41CB3867E6Q42552046-FA75A8C4-3EEF-4E90-828E-BC5A8B2680D4Q42552069-FA9AC863-97D6-4856-A9D3-2858223542D3Q47131130-6CA59662-4145-461B-8029-95DBA3E6C208Q48514792-5220F3A0-5621-4AF8-A73F-95F770872784
P2860
Phase I to II study of pleurectomy/decortication and intraoperative intracavitary hyperthermic cisplatin lavage for mesothelioma.
description
2006 nî lūn-bûn
@nan
2006 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Phase I to II study of pleurec ...... latin lavage for mesothelioma.
@ast
Phase I to II study of pleurec ...... latin lavage for mesothelioma.
@en
Phase I to II study of pleurec ...... latin lavage for mesothelioma.
@nl
type
label
Phase I to II study of pleurec ...... latin lavage for mesothelioma.
@ast
Phase I to II study of pleurec ...... latin lavage for mesothelioma.
@en
Phase I to II study of pleurec ...... latin lavage for mesothelioma.
@nl
prefLabel
Phase I to II study of pleurec ...... latin lavage for mesothelioma.
@ast
Phase I to II study of pleurec ...... latin lavage for mesothelioma.
@en
Phase I to II study of pleurec ...... latin lavage for mesothelioma.
@nl
P2093
P356
P1476
Phase I to II study of pleurec ...... latin lavage for mesothelioma.
@en
P2093
Beow Y Yeap
Lambros Zellos
Leah Capalbo
Lucian R Chirieac
Michael T Jaklitsch
Phillip M Hartigan
Raphael Bueno
Rene J Dekkers
William G Richards
P304
P356
10.1200/JCO.2005.04.6813
P407
P577
2006-04-01T00:00:00Z